Fox Run Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
|
|||||
|
2025
Q2 | $1.01M | Sell |
|
|||||
|
2025
Q1 | $1.63M | Buy |
|
|||||
|
2024
Q4 | $540K | Sell |
|
|||||
|
2024
Q3 | $1.01M | Buy |
|
|||||
|
2024
Q2 | $469K | Sell |
|
|||||
|
2024
Q1 | $869K | Sell |
|
|||||
|
2023
Q4 | $1.04M | Buy |
|
|||||
|
2023
Q3 | $442K | Sell |
|
|||||
|
2023
Q2 | $1.6M | Buy |
|
|||||
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $227K | Sell |
|
|||||
|
2022
Q1 | $875K | Buy |
|
|||||
|
2021
Q4 | $661K | Buy |
|
|||||
|
2021
Q3 | $244K | Buy |
|
|||||
|
2016
Q3 | – | Sell |
|
|||||
|
2016
Q2 | $825K | Buy |
|
|||||
|
2016
Q1 | $610K | Buy |
|